title: Effects of angiotensin, vasopressin and atrial natriuretic peptide on intraocular pressure in anesthetized rats.
abstract: The effects of atrial natriuretic peptide (ANP), vasopressin (AVP) and angiotensin (ANG) on blood and intraocular pressures of pentobarbital anesthetized rats were evaluated following intravenous, intracerebroventricular or anterior chamber routes of administration. Central injections did not affect intraocular pressure. Equipressor intravenous infusions of ANG raised, whereas AVP decreased, intraocular pressure. Direct infusions of a balanced salt solution (0.175 microliter/min) raised intraocular pressure between 30 and 60 min. Adding ANG or ANP slightly reduced this solvent effect but AVP was markedly inhibitory. An AVP-V1 receptor antagonist reversed the blunting of the solvent-induced rise by the peptide, indicating receptor specificity. Acetazolamide pretreatment lowered intraocular pressure, but the solvent-induced rise in intraocular pressure and inhibition by AVP still occurred without altering the temporal pattern. Thus, these effects appear unrelated to aqueous humor synthesis rate. The data support the possibility of intraocular pressure regulation by peptides acting from the blood and aqueous humor.
authors.affiliation: Department of Pharmacology, College of Medicine, Pennsylvania State University, Hershey 17033, USA.
authors.forename: D E
authors.initials: DE
authors.lastname: Palm
authors.forename: S G
authors.initials: SG
authors.lastname: Shue
authors.forename: L C
authors.initials: LC
authors.lastname: Keil
authors.forename: C D
authors.initials: CD
authors.lastname: Balaban
authors.forename: W B
authors.initials: WB
authors.lastname: Severs
mesh_terms: D000086:Acetazolamide / Q000494:pharmacology; D000758:Anesthesia; D000804:Angiotensin II / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D057911:Angiotensin Receptor Antagonists; D000818:Animals; D000867:Anterior Chamber; D065092:Antidiuretic Hormone Receptor Antagonists; D009320:Atrial Natriuretic Factor / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D007262:Infusions, Intravenous; D007267:Injections; D007276:Injections, Intraventricular; D007429:Intraocular Pressure / Q000187:drug effects*; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D014662:Vasoconstrictor Agents / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D014667:Vasopressins / Q000037:antagonists & inhibitors / Q000494:pharmacology*
chemical_list: D057911:Angiotensin Receptor Antagonists; D065092:Antidiuretic Hormone Receptor Antagonists; D014662:Vasoconstrictor Agents; D014667:Vasopressins; D000804:Angiotensin II; D009320:Atrial Natriuretic Factor; D000086:Acetazolamide